| Literature DB >> 35896017 |
Yoshimasa Kawazoe1, Kiminori Shimamoto1, Daisaku Shibata1, Emiko Shinohara1, Hideaki Kawaguchi2,3, Tomotaka Yamamoto4.
Abstract
BACKGROUND: Falls may cause elderly people to be bedridden, requiring professional intervention; thus, fall prevention is crucial. The use of electronic health records (EHRs) is expected to provide highly accurate risk assessment and length-of-stay data related to falls, which may be used to estimate the costs and benefits of prevention. However, no studies to date have investigated the extent to which hospital stays could be shortened through fall avoidance resulting from the use of prediction tools.Entities:
Keywords: accident prevention; accidental falls; elderly; hospital; inpatients; machine learning; natural language processing; patient; prediction model; propensity score; risk assessment
Year: 2022 PMID: 35896017 PMCID: PMC9377461 DOI: 10.2196/37913
Source DB: PubMed Journal: JMIR Med Inform
Figure 1Flowchart of data collection and selection procedure.
Figure 2Period and variables of data extraction. DPC: diagnosis procedure combination; NSAID: nonsteroidal anti-inflammatory drug.
Figure 3Overview of the bidirectional encoder representations from transformers (BERT) classification model. The input document was divided into 510 tokens; classification [CLS] and separation [SEP] tokens were added at each end, and the input was sequential. All token embeddings output sequentially were used as inputs to the bidirectional long short-term memory (Bi-LSTM) model, and the 50-dimensional vectors in the forward and reverse directions that were output for each were combined to form 100-dimensional vectors. The feature value obtained from the document was set as the sum of each dimension of the multiple 100-dimensional vectors, which were converted linearly and output as binary fallen or unfallen values using a sigmoid function. FFN: feedforward neural network.
Statistics of fall-related variables.
| Variables | Fallen cases | Unfallen cases (n=70,586) | Multivariate regressiona | Standardized difference | ||||||||||
|
|
|
| Adjusted odds ratio (95% CI) | Before matching (n=1728 fallen cases, n=70,586 unfallen cases) | After matching (n=1728 fallen cases, n=1728 unfallen cases) | |||||||||
| Hospital days, mean (SD) | 30.3 (23.7) | 10.6 (6.8) | N/Ac | N/A | N/A | N/A | ||||||||
|
| ||||||||||||||
|
| Age (years), mean (SD) | 76.5 (6.8) | 74.3 (SD 6.4) | 1.03 (1.02-1.03)d | <.001 | 0.33 | –0.04 | |||||||
|
| Sex (male 0, female 1), positive rate (%) | 40.6 | 43.8 | 0.71 (0.63-0.80) | <.001 | –0.06 | 0.01 | |||||||
|
| ADLe Eats, positive rate (%) | 9.2 | 2.4 | 1.08 (0.83-1.40) | .57 | 0.29 | 0.04 | |||||||
|
| ADL Bathe, positive rate (%) | 19.2 | 5.5 | 1.37 (1.06-1.77) | .02 | 0.43 | 0.04 | |||||||
|
| ADL Dressingf, positive rate (%) | 15.3 | 4.4 | 0.76 (0.57-1.02) | .07 | 0.37 | 0.04 | |||||||
|
| ADL Transferringg, positive rate (%) | 26.2 | 8.6 | 1.79 (1.48-2.18) | <.001 | 0.48 | 0.02 | |||||||
|
| ADL Continenceh, positive rate (%) | 13.0 | 3.5 | 1.04 (0.80-1.37) | .75 | 0.35 | 0.05 | |||||||
|
| Unconsciousness (JCSi 0,≠0), positive rate (%) | 18.1 | 5.6 | 1.70 (1.44-2.00) | <.001 | 0.39 | 0.04 | |||||||
|
| Emergency transport, positive rate (%) | 8.6 | 3.9 | 0.96 (0.78-1.17) | .68 | 0.20 | –0.01 | |||||||
|
| Cognitive disorder, positive rate (%) | 11.1 | 4.0 | 1.10 (0.92-1.32) | .28 | 0.01 | 0.01 | |||||||
|
| Chemotherapy admission, positive rate (%) | 11.7 | 11.4 | 1.08 (0.91-1.27) | .39 | 0.27 | 0.02 | |||||||
|
| Past fallen, positive rate (%) | 8.1 | 3.5 | 1.37 (1.13-1.65) | .001 | 0.20 | 0.01 | |||||||
|
| ||||||||||||||
|
| Certain infectious and parasitic diseases (A00-B99), positive rate (%) | 8.6 | 6.8 | 0.98 (0.82-1.17) | .78 | 0.07 | –0.02 | |||||||
|
| Neoplasms (C00-D48), positive rate (%) | 40.8 | 41.1 | 1.10 (0.97-1.25) | .12 | –0.01 | –0.01 | |||||||
|
| Diseases of the blood and blood-forming organs (D50-D89), positive rate (%) | 8.3 | 6.3 | 1.28 (1.07-1.53) | .01 | 0.08 | –0.002 | |||||||
|
| Endocrine, nutritional, and metabolic diseases (E00-E90), positive rate (%) | 23.8 | 18.5 | 1.09 (0.96-1.24) | .19 | 0.13 | –0.01 | |||||||
|
| Mental and behavioral disorders (F00-F99), positive rate (%) | 4.6 | 1.1 | 2.09 (1.61-2.71) | <.001 | 0.21 | 0.05 | |||||||
|
| Diseases of the nervous system (G00-G99), positive rate (%) | 8.4 | 4.7 | 1.14 (0.95-1.38) | .16 | 0.16 | –0.001 | |||||||
|
| Diseases of the eye and adnexa (H00-H59), positive rate (%) | 3.8 | 13.3 | 0.47 (0.36-0.61) | <.001 | –0.35 | 0.04 | |||||||
|
| Diseases of the ear and mastoid process (H60-H95), positive rate (%) | 0.3 | 0.8 | 0.47 (0.19-1.14) | .10 | –0.07 | 0.01 | |||||||
|
| Diseases of the circulatory system (I00-I99), positive rate (%) | 33.9 | 26.1 | 1.15 (1.02-1.29) | .02 | 0.17 | 0.00 | |||||||
|
| Diseases of the respiratory system (J00-J99), positive rate (%) | 9.5 | 6.2 | 1.01 (0.85-1.20) | .91 | 0.12 | –0.01 | |||||||
|
| Diseases of the digestive system (K00-K93), positive rate (%) | 17.8 | 16.6 | 0.77 (0.67-0.87) | <.001 | 0.03 | –0.01 | |||||||
|
| Diseases of the skin and subcutaneous tissue (L00-L99), positive rate (%) | 3.0 | 1.6 | 1.46 (1.09-1.95) | .01 | 0.09 | –0.00 | |||||||
|
| Diseases of the musculoskeletal system and connective tissue (M00-M99), positive rate (%) | 11.9 | 8.4 | 1.22 (1.04-1.43) | .02 | 0.11 | 0.00 | |||||||
|
| Diseases of the genitourinary system (N00-N99), positive rate (%) | 10.0 | 7.3 | 0.94 (0.79-1.12) | .50 | 0.10 | –0.003 | |||||||
|
| Pregnancy, perinatal period, congenital malformations (O00-Q99), positive rate (%) | 0.3 | 0.4 | 1.03 (0.42-2.52) | .94 | –0.10 | 0.00 | |||||||
|
| Symptoms, signs, and abnormal clinical and laboratory findings (R00-R99), positive rate (%) | 5.8 | 3.3 | 1.03 (0.83-1.28) | .80 | 0.12 | –0.01 | |||||||
|
| Injury, poisoning and certain other consequences of external causes (S00-T98), positive rate (%) | 5.1 | 3.1 | 1.11 (0.88-1.40) | .38 | 0.10 | 0.00 | |||||||
|
| ||||||||||||||
|
| Low hemoglobin (3.9% missing data), positive rate (%) | 71.8 | 57.5 | 1.34 (1.19-1.53) | <.001 | 0.24 | –0.04 | |||||||
|
| Low total protein or albumin (5.0% missing data), positive rate (%) | 48.7 | 33.8 | 1.20 (1.08-1.34) | .001 | 0.32 | –0.04 | |||||||
|
| High blood urea nitrogen (4.4% missing data), positive rate (%) | 3.4 | 1.6 | 1.20 (0.90-1.61) | .22 | 0.12 | –0.004 | |||||||
|
| High liver enzymes (ASTj, ALTk; 4.0% missing data), positive rate (%) | 6.0 | 3.6 | 1.22 (0.98-1.52) | .07 | 0.12 | –0.01 | |||||||
|
| Low plasma glucose (19.7% missing data), positive rate (%) | 2.5 | 1.7 | 1.14 (0.80-1.62) | .48 | 0.05 | –0.01 | |||||||
|
| Abnormal electrolytes (Na, K, Cl; 12.1% missing data), positive rate (%) | 35.1 | 21.6 | 1.40 (1.26-1.57) | <.001 | 0.32 | –0.02 | |||||||
|
| High C-reactive protein (6.8% missing data), positive rate (%) | 10.9 | 5.0 | 1.12 (0.94-1.34) | .21 | 0.22 | –0.005 | |||||||
|
| ||||||||||||||
|
| Hypnotics and sedatives, antianxietics | 37.4 | 30.7 | 1.09 (0.97-1.22) | .13 | 0.13 | –0.001 | |||||||
|
| Antiepileptic | 4.4 | 1.8 | 1.30 (1.00-1.69) | .05 | 0.16 | 0.03 | |||||||
|
| NSAIDsl | 43.5 | 32.6 | 1.21 (1.08-1.36) | .001 | 0.22 | –0.03 | |||||||
|
| Antiparkinsonism | 3.2 | 1.0 | 1.61 (1.18-2.21) | .003 | 0.16 | 0.02 | |||||||
|
| Antipsychotic | 21.4 | 9.6 | 1.44 (1.25-1.66) | <.001 | 0.33 | 0.02 | |||||||
|
| Other neuroactive agents | 13.8 | 6.6 | 1.19 (1.01-1.39) | .03 | 0.23 | 0.01 | |||||||
|
| Muscle relaxant | 0.3 | 0.1 | 1.70 (0.60-4.85) | .32 | 0.03 | 0.01 | |||||||
|
| Diuretic | 23.4 | 13.7 | 1.33 (1.16-1.53) | <.001 | 0.24 | –0.003 | |||||||
|
| Antihypertensive | 31.4 | 25.9 | 0.88 (0.77-1.00) | .05 | 0.11 | –0.01 | |||||||
|
| Diabetes treatment | 15.9 | 12.7 | 1.08 (0.92-1.26) | .48 | 0.09 | –0.01 | |||||||
|
| Narcotic analgesic | 3.3 | 1.4 | 1.11 (0.81-1.51) | .52 | 0.12 | –0.001 | |||||||
|
| Purgative medicine | 38.3 | 32.6 | 1.09 (0.97-1.22) | .15 | 0.11 | 0.00 | |||||||
|
| Polypharmacy (>10 drugs) | 48.7 | 35.8 | 1.02 (0.89-1.17) | .77 | 0.26 | –0.004 | |||||||
aMultivariate logistic regression on the results of missing value estimation by the multiple imputation method.
bBased on the two-tailed Z-test for a coefficient of zero.
cN/A: not applicable.
dThe odds ratio for age was calculated by univariate logistic regression with the age range from 65 to 99 years equally transformed from 0.0 to 1.0.
eADL: activities of daily living.
fAssistance is required for dressing or personal maintenance.
gAssistance is required for walking, going up and down stairs, getting into/out of bed or chair, or going to the toilet.
hAssistance is required for either defecation or urination.
iJCS: Japan Coma Scale, which has been widely used to assess patients’ consciousness level in Japan.
jAST: aspartate aminotransferase.
kALT: alanine aminotransferase.
lNSAID: nonsteroidal anti-inflammatory drug.
Figure 4Box-and-whisker plots of the propensity scores (a) before matching and (b) after matching. Boxes show lower and upper IQR, and whiskers show the highest and lowest values, excluding outliers (>1.5 times IQR; rounds). Propensity score matching was performed using one-to-one nearest-neighbor matching with the replacement method on fallen cases.
Sensitivity analysis for P value and Rosenbaum bounds estimates (average values calculated over 20 imputed data sets) to unobserved biases.
| Γa | Maximum | Minimum Hodges–Lehmann point estimate (days) |
| 1.0 | <.001 | 14.1 |
| 2.0 | <.001 | 8.6 |
| 3.0 | <.001 | 6.0 |
| 4.0 | <.001 | 4.1 |
| 5.0 | <.001 | 2.9 |
| 6.0 | <.001 | 2.0 |
| 7.0 | 0.01 | 1.1 |
| 7.5 | .05 | 0.8 |
| 8.0 | .16 | 0.5 |
aΓ: odds of differential assignment due to unobserved factors.
bThe P value is based on a one-tailed Wilcoxon signed-rank test for the null hypothesis of no extension of hospital stay caused by falls.
Performance comparison of machine learning models with input data categories.
| Model | Input data | Evaluation accuracya | ||||||
|
| 49 fall-related factors | Clinical text | AUCb | F1c | Sensitivity | Specificity | Precision | |
| Model 1: MLPd | ✓ |
| 0.735 | 0.090 | 0.662 | 0.708 | 0.048 | |
| Model 2: BERTe+Bi-LSTMf |
| ✓ | 0.851 | 0.165 | 0.737 | 0.839 | 0.093 | |
| Model 3: BERT+Bi-LSTM | ✓ | ✓ | 0.850 | 0.138 | 0.794 | 0.776 | 0.076 | |
aThe accuracies are the average values of two cross-validation tests based on the cutoff determined by the Youden index.
bAUC: area under the receiver operating characteristic curve.
cF1 is the harmonic mean of precision and recall.
dMLP: multilayer perceptron.
eBERT: bidirectional encoder representations from transformers.
fBi-LSTM: bidirectional long short-term memory.
Cross-table summary of the results of the two Model 3 cross-validations. The cutoff was determined using the Youden index.
| Predictions | Fallen cases | Unfallen cases | Sum |
| Predicted fallen cases | 168 | 1638 | 1806 |
| Predicted unfallen cases | 60 | 8520 | 8580 |
| Sum | 228 | 10,158 | 10,386 |
Estimated hospital days reduced by interventions based on Model 2 predictions (sensitivity 73.7%, precision 9.3%).
| Scenario | ATETa (days) | Fall prevention rate (%) | Reduced length of hospital stay (number of days per day of interventions) | Hospital stays that could not be reduced (number of days per day of interventions) | Net reduced length of hospital stay (number of days per day of interventions) | Net reduced daily medical costs (Yen per day)b |
| Scenario 1 | 17.8 | 100 | 0.154 | 0.055 | 0.099 | 3950 |
| Scenario 2 | 17.8 | 25 | 0.035 | 0.012 | 0.022 | 886 |
| Scenario 3 | 8.6 | 100 | 0.069 | 0.025 | 0.044 | 1769 |
| Scenario 4 | 8.6 | 25 | 0.017 | 0.006 | 0.011 | 420 |
aATET: average treatment effect on treatment.
bMedical costs were estimated at 40,000 Yen per day (US $1=~136 Yen).
Figure 5Estimated net reduced daily medical costs by interventions based on Model 2 sensitivity. The maximum points in Scenarios 1-4 are indicated by a circle with † and their values are 3951, 886, 1768, and 420 (Yen; US $1=~136 Yen), respectively. These are taken with a sensitivity of 0.737; the sensitivity is the same as determined using the Youden index. The points with 0.95 sensitivity in Scenarios 1-4 are indicated by a circle with ††, and their values are 2249, 538, 1054, and 258 (Yen), respectively.